Stock MDB MEDICOFARMA BIOTECH SA
Add to a list
To use this feature you must be a member
Log inSign up

Financials Medicofarma Biotech SA

Equities

MDB

PLINBOK00010

Biotechnology & Medical Research

End-of-day quote Warsaw S.E.
Other stock markets
 18:00:00 2024-05-30 EDT 		5-day change 1st Jan Change
0.832 PLN -0.72% Intraday chart for Medicofarma Biotech SA -3.26% -23.32%
05-13 Medicofarma Biotech SA Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
02-06 Medicofarma Biotech SA Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 2.849 1.357 2.09 19.81 115.5 78.51
Enterprise Value (EV) 1 2.488 1.003 2.093 20.13 115.5 78.01
P/E ratio 51.2 x 27.6 x -6.06 x -21.6 x -537 x -49.4 x
Yield - - - - - -
Capitalization / Revenue 0.56 x 0.27 x 0.66 x 5.43 x 34.6 x 18.5 x
EV / Revenue 0.49 x 0.2 x 0.66 x 5.52 x 34.6 x 18.3 x
EV / EBITDA 36.9 x 9.58 x -6.18 x -59.1 x 173 x 454 x
EV / FCF 162 x -2.74 x -8.52 x 101 x -45.5 x 78.6 x
FCF Yield 0.62% -36.5% -11.7% 0.99% -2.2% 1.27%
Price to Book 2.9 x 1.31 x 3.04 x -86.6 x 8.14 x 6.22 x
Nbr of stocks (in thousands) 6,784 6,784 6,784 6,784 67,965 67,978
Reference price 2 0.4200 0.2000 0.3080 2.920 1.700 1.155
Announcement Date 4/10/18 5/10/19 6/1/20 3/22/21 5/30/22 5/30/23
1PLN in Million2PLN
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 5.076 4.969 3.185 3.65 3.337 4.252
EBITDA 1 0.0674 0.1047 -0.3384 -0.3407 0.6665 0.1719
EBIT 1 0.0215 0.0752 -0.369 -0.3636 -0.2846 -1.577
Operating Margin 0.42% 1.51% -11.59% -9.96% -8.53% -37.07%
Earnings before Tax (EBT) 1 0.0579 0.0365 -0.3449 -0.8954 -0.2152 -1.589
Net income 1 0.0556 0.0491 -0.3449 -0.9159 -0.2152 -1.589
Net margin 1.1% 0.99% -10.83% -25.09% -6.45% -37.38%
EPS 2 0.008202 0.007239 -0.0508 -0.1350 -0.003166 -0.0234
Free Cash Flow 1 0.0154 -0.3666 -0.2458 0.1993 -2.536 0.9918
FCF margin 0.3% -7.38% -7.72% 5.46% -75.99% 23.32%
FCF Conversion (EBITDA) 22.84% - - - - 577.09%
FCF Conversion (Net income) 27.66% - - - - -
Dividend per Share - - - - - -
Announcement Date 4/10/18 5/10/19 6/1/20 3/22/21 5/30/22 5/30/23
1PLN in Million2PLN
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - 0 0.32 - -
Net Cash position 1 0.36 0.35 - - 0.08 0.51
Leverage (Debt/EBITDA) - - -0.009458 x -0.9463 x - -
Free Cash Flow 1 0.02 -0.37 -0.25 0.2 -2.54 0.99
ROE (net income / shareholders' equity) 5.83% 4.87% -40.1% -399% -3.08% -11.9%
ROA (Net income/ Total Assets) 0.81% 2.76% -15.2% -25.5% -2.07% -5.95%
Assets 1 6.894 1.778 2.263 3.595 10.38 26.73
Book Value Per Share 2 0.1400 0.1500 0.1000 -0.0300 0.2100 0.1900
Cash Flow per Share 2 0.0500 0.0500 0.0100 0 0 0.0100
Capex 1 0.01 - - - 2.3 1.21
Capex / Sales 0.13% - - - 68.9% 28.41%
Announcement Date 4/10/18 5/10/19 6/1/20 3/22/21 5/30/22 5/30/23
1PLN in Million2PLN
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
MEDICOFARMA BIOTECH SA Stock Medicofarma Biotech SA
-23.32% 14.35M
MODERNA, INC. Stock Moderna, Inc.
+43.36% 54.63B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-5.31% 39.92B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+14.75% 26.86B
CELLTRION, INC. Stock Celltrion, Inc.
-12.56% 26.22B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-22.45% 18.78B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+25.12% 12.21B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+0.04% 12.16B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+26.04% 11.94B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-11.83% 10.74B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. MDB Stock
  4. Financials Medicofarma Biotech SA